Latest News | Comm Min Withdraws Rule for Track, Trace System for Export of Drug Formulations

Get latest articles and stories on Latest News at LatestLY. The Commerce Ministry on Friday said it has withdrawn the provisions related to the track and trace system for pharmaceutical exports under the foreign trade policy.

New Delhi, Jan 31 (PTI) The Commerce Ministry on Friday said it has withdrawn the provisions related to the track and trace system for pharmaceutical exports under the foreign trade policy.

The implementation of the authentication system for drug formulations being exported will be undertaken by the Ministry of Health and Family Welfare in line with the provisions under Drug Rules 1945, according to a public notice of the Directorate General of Foreign Trade (DGFT).

Also Read | 8th Pay Commission: Nirmala Sitharaman To Announce Official 8th CPC Implementation Date in Union Budget 2025? Check Details Here.

"The DGFT has decided to streamline export regulations by aligning with the evolving regulatory framework of the Ministry of Health & Family Welfare. Accordingly, the provisions related to the track and trace system for pharmaceutical exports under the Foreign Trade Policy are being withdrawn," the ministry said.

The system, introduced on January 10, 2011, mandated barcoding at various packaging levels.

Also Read | Central Bank of India Recruitment 2025: Applications Open for 1000 Credit Officer Posts at centralbankofindia.co.in, Know Steps To Apply.

While tertiary and secondary packaging requirements were successfully implemented in 2011 and 2013, primary-level barcoding and parent-child data uploading faced operational challenges and were repeatedly deferred, with the last extension valid until February 1, 2025.

It added that the health ministry has already implemented barcode/QR code requirements for 300 drug brands under the Drugs Rules, 1945, from August 1, 2023, with plans for further expansion.

The move also assumes significance as most export destinations have their own serialization requirements, ensuring product traceability without additional domestic regulations.

"With this step, DGFT is enhancing ease of doing business for pharmaceutical exporters while ensuring regulatory coherence," it added.

(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)

Share Now

Share Now